Light Dean, Haas Roni, Yazbak Mahmoud, Elfand Tal, Blau Tal, Lamm Ayelet T
Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
Front Genet. 2021 Jul 23;12:686851. doi: 10.3389/fgene.2021.686851. eCollection 2021.
Adenosine to inosine (A-to-I) RNA editing, the most prevalent type of RNA editing in metazoans, is carried out by adenosine deaminases (ADARs) in double-stranded RNA regions. Several computational approaches have been recently developed to identify A-to-I RNA editing sites from sequencing data, each addressing a particular issue. Here, we present RNA Editing Sites Identification and Classification (RESIC), an efficient pipeline that combines several approaches for the detection and classification of RNA editing sites. The pipeline can be used for all organisms and can use any number of RNA-sequencing datasets as input. RESIC provides (1) the detection of editing sites in both repetitive and non-repetitive genomic regions; (2) the identification of hyper-edited regions; and (3) optional exclusion of polymorphism sites to increase reliability, based on DNA, and ADAR-mutant RNA sequencing datasets, or SNP databases. We demonstrate the utility of RESIC by applying it to human, successfully overlapping and extending the list of known putative editing sites. We further tested changes in the patterns of A-to-I RNA editing, and RNA abundance of ADAR enzymes, following SARS-CoV-2 infection in human cell lines. Our results suggest that upon SARS-CoV-2 infection, compared to mock, the number of hyper editing sites is increased, and in agreement, the activity of ADAR1, which catalyzes hyper-editing, is enhanced. These results imply the involvement of A-to-I RNA editing in conceiving the unpredicted phenotype of COVID-19 disease. RESIC code is open-source and is easily extendable.
腺苷到肌苷(A-to-I)RNA编辑是后生动物中最普遍的RNA编辑类型,由双链RNA区域中的腺苷脱氨酶(ADARs)进行。最近开发了几种计算方法来从测序数据中识别A-to-I RNA编辑位点,每种方法都解决了一个特定问题。在这里,我们提出了RNA编辑位点识别和分类(RESIC),这是一种有效的流程,它结合了几种用于检测和分类RNA编辑位点的方法。该流程可用于所有生物,并且可以使用任意数量的RNA测序数据集作为输入。RESIC提供:(1)在重复和非重复基因组区域中检测编辑位点;(2)识别高编辑区域;(3)基于DNA、ADAR突变RNA测序数据集或SNP数据库,可选择排除多态性位点以提高可靠性。我们通过将RESIC应用于人类来证明其效用,成功地重叠并扩展了已知推定编辑位点的列表。我们进一步测试了人类细胞系中感染SARS-CoV-2后A-to-I RNA编辑模式和ADAR酶RNA丰度的变化。我们的结果表明,与模拟感染相比,SARS-CoV-2感染后高编辑位点的数量增加,并且催化高编辑的ADAR1的活性增强,这与之一致。这些结果暗示A-to-I RNA编辑参与了COVID-19疾病不可预测表型的形成。RESIC代码是开源的,并且易于扩展。